about
Neuropsychology, social cognition and global functioning among bipolar, schizophrenic patients and healthy controls: preliminary dataNew approaches to the pharmacological management of generalized anxiety disorder.Pharmacokinetic evaluation of fluvoxamine for the treatment of anxiety disorders.Biological aspects and candidate biomarkers for psychotic bipolar disorder: A systematic review.Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: A naturalistic study.Psychiatric Conditions in Parkinson Disease: A Comparison With Classical Psychiatric Disorders.Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review.Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder.Are obstetrical complications really involved in the etiology and course of schizophrenia and mood disorders?Sex Steroids and Major Psychoses: Which Role for DHEA-S and Progesterone.Correlation between neuropsychological and social cognition measures and symptom dimensions in schizophrenic patients.Psychotic versus non-psychotic major depressive disorder: a comparative naturalistic study.Is trazodone more effective than clomipramine in major depressed outpatients? A single-blind study with intravenous and oral administration.Obesity and obstetric complications are associated with rapid-cycling in Italian patients with bipolar disorder.Are antidepressants equally effective in the long-term treatment of major depressive disorder?The impact of mood episodes and duration of illness on cognition in bipolar disorder.General and social cognition in remitted first-episode schizophrenia patients: a comparative study.IQ as a Cognitive Marker of Genetic Liability in Relatives of Schizophrenia PatientsA miRNome analysis of drug-free manic psychotic bipolar patients versus healthy controls
P50
Q30681799-77C20268-8693-465B-8F0B-87E1A261D9FCQ38071131-80CF0E6E-C751-488A-B4B8-BE7DBA21DF8CQ38366480-43435028-40A0-4F45-BC07-F12190ED59B8Q38394902-61A427A1-C069-4DC0-AD21-97B865CEBEC4Q38482868-3D59F881-82E0-431D-BD48-89F3C00E2B71Q38588201-20FDBC43-00FB-43FC-8D7B-73D711960A83Q38738414-5F120F33-18BD-4297-8EAD-9904E89B5382Q39079619-49DD8AEC-ECBD-4E1A-95FD-C4F8298A6DD9Q39731510-1E6475DD-13A4-4198-8153-7924D623B339Q39834059-9647A989-BBD4-44BD-BDA5-ECD8448C7F24Q41387539-7EAD8791-B6EB-4AA8-94FE-11746D9F7D81Q43822343-720ABE1E-8596-4767-9087-440F5E36A707Q47695816-075ACE04-FFE9-443E-8E61-DBE30601B976Q47896120-059016DE-D466-4743-9B17-122DB8F83637Q48176372-1C89AB66-DFBF-4175-A128-3A3912E153A9Q48256865-FC3F27FB-84A6-4E83-9B63-C6DAE8C17AE5Q48702004-115A584C-E666-4C9C-B877-046617EB40CAQ85698591-A1D10EF5-5D2A-4540-AA53-98365D0DFF00Q92679064-989F74B0-15BE-4CF9-A169-8E5814336F7A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8493-0779
@en
name
Alice Caldiroli
@ast
Alice Caldiroli
@en
Alice Caldiroli
@es
Alice Caldiroli
@nl
type
label
Alice Caldiroli
@ast
Alice Caldiroli
@en
Alice Caldiroli
@es
Alice Caldiroli
@nl
prefLabel
Alice Caldiroli
@ast
Alice Caldiroli
@en
Alice Caldiroli
@es
Alice Caldiroli
@nl
P106
P1153
55537608900
P21
P31
P496
0000-0002-8493-0779